用药监测与调整：若患者开始接受利鲁唑治疗，需通过临床观察和肝功能检查密切监测药物不良反应。当患者出现持续性不良反应、处于疾病终末期（接受姑息治疗）或已行气管切开术时，应立即停用利鲁唑。

A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 accompanies ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential ...

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...

Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple ...

DelveInsight's, “Amyotrophic Lateral Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline ...

A new study indicates that ALS and MS have an extremely high geographic association, even after controlling for race, gender, ...

Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.